Belite Bio (BLTE) Shares Outstanding (2020 - 2026)

Belite Bio's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $680.0 for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) fell 100.0% year-over-year to $680.0; the TTM figure through Mar 2026 stood at $680.0 (down 100.0% YoY), while the FY2025 annual figure was $33.5 million, up 9.82% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $680.0, down from $33.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $33.5 million in Q4 2025, with the low at $680.0 in Q1 2026.
• The 5-year median for Shares Outstanding (Entity) is $28.5 million (2023), against an average of $25.8 million.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) soared 108.74% in 2022, then tumbled 100.0% in 2026.
• Belite Bio's Shares Outstanding (Entity) stood at $20.0 million in 2022, then soared by 33.12% to $26.6 million in 2023, then rose by 14.83% to $30.5 million in 2024, then climbed by 9.82% to $33.5 million in 2025, then sank by 100.0% to $680.0 in 2026.
• Business Quant data shows BLTE's Shares Outstanding (Entity) at $680.0 in Q1 2026, $33.5 million in Q4 2025, and $32.6 million in Q3 2025.